Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giuseppa De Luca
Observed names:
DE LUCA, GIUSEPPA,
DE LUCA, Giuseppa,
De Luca, Giuseppa,
G. De Luca,
Luca, Giuseppa De
Institutions:
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
Ospedale Policlinico San Martino
Observed institutions:
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
Ospedale Policlinico San Martino
ORCID:
0000-0003-4877-1309
Observed ORCID:
0000-0003-4877-1309
OpenAlex ID:
A5034342437
Radiomic Detection of EGFR Mutations in NSCLC
2020
·
Giovanni Rossi
, Emanuele Barabino
, et al.
·
Cancer Research
·
118
Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients
2019
·
Mariella Dono
, Giuseppa De Luca
, et al.
·
Molecular Medicine
·
38
PDF
Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity
2023
·
Federica Barbieri
, Adriana Bajetto
, et al.
·
Neuro-Oncology
·
29
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients
2022
·
Silvia Marconi
, Michela Croce
, et al.
·
Cancers
·
18
PDF
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers
2023
·
Chiara M. Biatta
, Michele Paudice
, et al.
·
Frontiers in Immunology
·
16
PDF
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
2020
·
Paola Monti
, Marta Lionetti
, et al.
·
Scientific Reports
·
16
PDF
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors
2020
·
Fortunato Morabito
, Massimo Gentile
, et al.
·
Expert Opinion on Investigational Drugs
·
14
Performance of the OncomineTM Lung cfDNA Assay for Liquid Biopsy by NGS of NSCLC Patients in Routine Laboratory Practice
2020
·
Giuseppa De Luca
, Sonia Lastraioli
, et al.
·
Applied Sciences
·
13
PDF
The Opportunities and Challenges of Molecular Tagging Next-Generation Sequencing in Liquid Biopsy
2021
·
Giuseppa De Luca
, Mariella Dono
·
Molecular Diagnosis & Therapy
·
11
Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer
2022
·
Barbara Cardinali
, Giuseppa De Luca
, et al.
·
International Journal of Molecular Sciences
·
9
PDF
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study
2022
·
Giuseppa De Luca
, Giannamaria Cerruti
, et al.
·
Hematological Oncology
·
7
PDF
Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling
2020
·
Giuseppa De Luca
, Barbara Cardinali
, et al.
·
International Journal of Molecular Sciences
·
7
PDF
O-6-methylguanine-DNA methyltransferase promoter methylation can change in glioblastoma recurrence due to intratumor heterogeneity
2018
·
Valeria Barresi
, Maria Caffo
, et al.
·
Glioma
·
7
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients
2024
·
Francesca Parisi
, Giuseppa De Luca
, et al.
·
Cancer Treatment and Research Communications
·
4
Optimizing Molecular Diagnosis of Systemic Mastocytosis in the Era of KIT Tyrosine Kinase Inhibitors: Results of a Survey and of a Nationwide Proficiency Control Round of KIT D816V Mutation Testing Promoted By the RIMA (Rete Italiana MAstocitosi) Association
2024
·
Simona Soverini
, Cecilia Monaldi
, et al.
·
Blood
·
1
PDF
83P Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in eary high risk breast cancer: The CITUCEL trial update
2024
·
R. Borea
, B. Cardinali
, et al.
·
Annals of Oncology
·
1
PDF
PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience
2023
·
E. Monti
, S. Gay
, et al.
·
Journal of Endocrinological Investigation
·
1
Data from Radiomic Detection of EGFR Mutations in NSCLC
2023
·
Giovanni Rossi
, Emanuele Barabino
, et al.
Supplementary Figure 1 from Radiomic Detection of EGFR Mutations in NSCLC
2023
·
Giovanni Rossi
, Emanuele Barabino
, et al.
Supplementary Appendix from Radiomic Detection of EGFR Mutations in NSCLC
2023
·
Giovanni Rossi
, Emanuele Barabino
, et al.
Supplementary Figure 2 from Radiomic Detection of EGFR Mutations in NSCLC
2023
·
Giovanni Rossi
, Emanuele Barabino
, et al.
Supplementary Data from Radiomic Detection of EGFR Mutations in NSCLC
2023
·
Giovanni Rossi
, Emanuele Barabino
, et al.
Supplementary Appendix from Radiomic Detection of EGFR Mutations in NSCLC
2023
·
Giovanni Rossi
, Emanuele Barabino
, et al.
Supplementary Figure 1 from Radiomic Detection of EGFR Mutations in NSCLC
2023
·
Giovanni Rossi
, Emanuele Barabino
, et al.
Supplementary Figure 2 from Radiomic Detection of EGFR Mutations in NSCLC
2023
·
Giovanni Rossi
, Emanuele Barabino
, et al.
Show more works
View as search
Works count:
45
Citation count:
309
H-index:
9
I10-index:
9
Year
Topic
Type